Dyne Therapeutics Inc. (DYN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Dyne Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$16.98
+0.24% today
Market cap
$3.2B
Overall quality
39/100
Kronos AI 30-day
+9.2%
8 of 8 simulated paths end higher
Dyne Therapeutics Inc. (DYN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $3.2B. It trades at $16.98, up 0.24% today. Its overall quality score is 39 out of 100, ranked against the whole US market. 12 analysts' average target of $33.17 implies +95.3% from today's price. Kronos AI's 30-day forecast is +9.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $33.17 |
| Low – high | $10.00 – $50.00 |
| Analysts | 12 |
| Upside to average | +95.3% |
Kronos AI 30-day forecast
| Expected close | $18.50 (+9.2%) |
| Likely range | +4.9% … +11.6% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 38 |
| Solvency | 48 |
| Growth | 31 |
| Overall | 39 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.